Sustainability | May 20, 2022
Pharma companies with ESG more valuable say investors
When asked how to balance ESG with broader business goals, the panel was unanimous in its assessment that ESG is ‘good for business’
When asked how to balance ESG with broader business goals, the panel was unanimous in its assessment that ESG is ‘good for business’
Leading pharma companies are achieving rapid, large-scale performance improvements using a multifaceted approach that realizes short-term gains & builds long-term capabilities at the same time
This cost-effective tool will be of immense benefit to other high burden countries as well.
Union Minister of State for Science and Technology, Dr Jitendra Singh gave the award for the successful commercialization of indigenous technology on National Technology Day 2022
The company is preparing the response to the observations, which will be submitted to the USFDA within 15 business days
The new framework collaboration will support due diligence into ALSA’s potential investments, which will assist with their investment de-risking
The EBUS is designed to support the diagnosis and staging of various lung disorders
Glenmark Pharmaceuticals won Innovation of the Year award
This facility will design & develop instruments, perform product reliability performance testing and verification
The respective expertise of Lonza and Integral Molecular will benefit drug developers in the assessment of the risk for off-target binding and activation
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
